By Colin Kellaher
Axogen's top finance executive, Nir Naor, is leaving the developer of technologies for peripheral nerve regeneration and repair to pursue other interests.
Axogen on Thursday said Naor, who joined the Alachua, Fla., company as chief financial officer in December 2023, will step down from the post effective May 11 but will remain in an advisory capacity through July 1.
The company said Lindsey Hartley, currently vice president and corporate controller, will succeed Naor as finance chief, effective May 12.
Axogen said Hartley, who joined the company in 2021, will receive an annual base salary of $440,000 as chief financial officer, along with an annual bonus plan with a target of 50% of her base pay.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
May 08, 2025 08:25 ET (12:25 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.